Oncology Research2026，Vol.34Issue(5)：P.546-562,17.DOI:10.32604/or.2026.074140
Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions
Chanwoong Yoon 1Euihyeon Na 2Min Joo Choi 1Sang-Pil Yoon3
作者信息
- 1. Interdisciplinary Postgraduate Program in Biomedical Engineering,Graduate School,Jeju National University,Jeju,Republic of Korea
- 2. Department of Psychiatry,Soonchunhyang University Cheonan Hospital,Soonchunhyang University College of Medicine,Cheonan,Republic of Korea
- 3. Interdisciplinary Postgraduate Program in Biomedical Engineering,Graduate School,Jeju National University,Jeju,Republic of Korea Department of Anatomy,College of Medicine,Jeju National University,Jeju,Republic of Korea
- 折叠
摘要
关键词
Src inhibitor/drug resistance/epithelial-mesenchymal transition/sex determining region Y-box-2/colorectal cancer分类
医药卫生引用本文复制引用
Chanwoong Yoon,Euihyeon Na,Min Joo Choi,Sang-Pil Yoon..Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions[J].Oncology Research,2026,34(5):P.546-562,17.
